Can a primary‑care or internal‑medicine physician prescribe a Dexcom (continuous glucose monitor) for an inpatient with unstable type 1 diabetes who experiences rapid, unpredictable, life‑threatening hypoglycemia?

Yes, you can prescribe a Dexcom CGM for this patient—your specialty designation does not restrict you from ordering this life-saving technology for an inpatient with unstable diabetes and life-threatening hypoglycemia.

Guideline Support for Primary Care/Internal Medicine Prescribing

The 2023 Endocrine Society Clinical Practice Guideline explicitly recommends initiating continuous glucose monitoring in the inpatient setting for select patients at high risk for hypoglycemia 1. Your patient with rapid, unpredictable, life-threatening hypoglycemia fits squarely into their high-risk criteria 1:

• Impaired awareness of hypoglycemia
• Type 1 diabetes with variable glycemic control
• History of hypoglycemia during current admission
• Individuals with conditions predisposing to severe hypoglycemia

There is no requirement for specialist consultation to initiate inpatient CGM. The guidelines frame this as a clinical decision based on patient risk factors, not provider specialty 1.

Critical Implementation Requirements

Before prescribing, ensure your hospital has these elements in place 1:

• Trained staff who can manage CGM devices and interpret data
• Hospital policies supporting inpatient CGM use
• Hybrid monitoring protocol: CGM must be combined with periodic point-of-care blood glucose testing to validate accuracy—you cannot dose insulin based solely on CGM readings currently 1
• Data security infrastructure for patient privacy

Regulatory Context You Need to Know

CGM is NOT FDA-approved for inpatient use 1. However, the FDA currently has "enforcement discretion"—meaning they are not objecting to inpatient CGM use, particularly following COVID-19 emergency use authorization 1. This regulatory gray zone should not stop you from prescribing for a life-threatening indication, but document your clinical reasoning clearly.

Why This Patient Qualifies

Your patient's rapid, unpredictable, life-threatening hypoglycemia makes them an ideal candidate. CGM can detect hypoglycemia an average of 3 hours and 34 minutes before standard point-of-care testing 2. For severe nocturnal hypoglycemia (glucose <54 mg/dL), detection occurred up to 3 hours and 42 minutes earlier 2. This early warning system is potentially life-saving for your patient.

Practical Prescribing Steps

1. Order the CGM (Dexcom G6 has the most inpatient data 3, 4)
2. Document high-risk criteria in your order: life-threatening hypoglycemia, rapid unpredictable drops, type 1 diabetes
3. Specify hybrid protocol: Continue scheduled point-of-care glucose checks; use CGM for trend monitoring and hypoglycemia alerts
4. Involve nursing/diabetes team if available for device management
5. Plan for device removal before MRI or other contraindicated procedures 5

Common Pitfalls to Avoid

Do not use CGM readings alone to dose insulin—current hospital protocols require confirmatory point-of-care glucose before insulin adjustments 1. CGM consistently reads 20-45 mg/dL lower than point-of-care testing 2, which actually provides a safety margin against hypoglycemia.

Recognize accuracy limitations 5, 1:

• Hypotension/vasoconstriction/vasopressor use
• Severe dehydration or volume depletion
• Edema/anasarca
• High-dose acetaminophen (>4 g/day)
• Initial sensor warm-up period

If your patient has any of these conditions, CGM may not be accurate enough to use safely.

The Evidence Supporting Your Decision

The 2023 Endocrine Society guideline represents the most authoritative and recent guidance, explicitly stating: "We suggest initiation of continuous glucose monitoring (CGM) in the inpatient setting for select inpatients at high risk for hypoglycemia" 1. This is a conditional recommendation based on very low-certainty evidence, but the panel placed high value on preventing life-threatening hypoglycemia 1.

Real-world implementation data from Scripps Health demonstrated feasibility of CGM as standard of care for nearly 900 hospital encounters 4. Pediatric accuracy data showed 98% of readings in clinically acceptable ranges 3, and adult studies confirmed CGM could prevent hypoglycemic events hours before they would be detected by standard monitoring 2.

Your role as a primary care/internal medicine physician does not limit your ability to prescribe this technology—your patient's clinical need and your hospital's infrastructure are the determining factors.